Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
Search results for: rituximab
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
Fellow’s Forum Case Report: When Pulmonary Symptoms Point to Rheumatic Disease
A 48-year-old man with diffuse arthralgias and acute respiratory failure is diagnosed with antisynthetase syndrome
EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease
How to determine which tests to order, how to interpret them, and how to decide on the right treatment course
Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients
The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants
EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis
Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
Ethics Forum: Ethics of Infusions in the Face of A Professional Conflict
An infusion prescription ordered by a rheumatologist, but changed by a hematologist, raises dilemmas concerning a patient’s continuity of care
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 45
- Next Page »